These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 17307325

  • 1. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.
    Kuhn J, Bewermeyer H, Miyajima H, Takahashi Y, Kuhn KF, Hoogenraad TU.
    Brain Dev; 2007 Aug; 29(7):450-3. PubMed ID: 17307325
    [Abstract] [Full Text] [Related]

  • 2. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
    Hofmann WP, Welsch C, Takahashi Y, Miyajima H, Mihm U, Krick C, Zeuzem S, Sarrazin C.
    Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675
    [Abstract] [Full Text] [Related]

  • 3. Aceruloplasminemia: an update.
    Kono S.
    Int Rev Neurobiol; 2013 Sep; 110():125-51. PubMed ID: 24209437
    [Abstract] [Full Text] [Related]

  • 4. [A case of aceruloplasminemia presenting as cerebellar ataxia with homozygous mutation nt2602 delG].
    Nagata M, Takiyama Y, Shimazaki H, Nakano I, Miyajima H.
    No To Shinkei; 2004 Oct; 56(10):885-9. PubMed ID: 15609677
    [Abstract] [Full Text] [Related]

  • 5. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.
    Kono S, Suzuki H, Takahashi K, Takahashi Y, Shirakawa K, Murakawa Y, Yamaguchi S, Miyajima H.
    Gastroenterology; 2006 Jul; 131(1):240-5. PubMed ID: 16831606
    [Abstract] [Full Text] [Related]

  • 6. [Aceruloplasminemia].
    Miyajima H.
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1290-2. PubMed ID: 11464482
    [Abstract] [Full Text] [Related]

  • 7. Central nervous system involvement in a rare genetic iron overload disorder.
    Bethlehem C, van Harten B, Hoogendoorn M.
    Neth J Med; 2010 Oct; 68(10):316-8. PubMed ID: 21071777
    [Abstract] [Full Text] [Related]

  • 8. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
    Meral Gunes A, Sezgin Evim M, Baytan B, Iwata A, Hida A, Avci R.
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
    [Abstract] [Full Text] [Related]

  • 9. Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis.
    Pérez-Aguilar F, Burguera JA, Benlloch S, Berenguer M, Rayón JM.
    J Hepatol; 2005 Jun; 42(6):947-9. PubMed ID: 15885371
    [Abstract] [Full Text] [Related]

  • 10. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
    Pelucchi S, Pelloni I, Arosio C, Mariani R, Piperno A.
    Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
    [No Abstract] [Full Text] [Related]

  • 11. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M, Zimmer V, Schleithoff L, Wonney K, Viera J, Zimmer A, Hübschen U, Bohle RM, Grünhage F, Lammert F.
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract] [Full Text] [Related]

  • 12. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
    [Abstract] [Full Text] [Related]

  • 13. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.
    Fasano A, Colosimo C, Miyajima H, Tonali PA, Re TJ, Bentivoglio AR.
    Mov Disord; 2008 Apr 15; 23(5):751-5. PubMed ID: 18200628
    [Abstract] [Full Text] [Related]

  • 14. Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.
    Melgari JM, Marano M, Quattrocchi CC, Piperno A, Arosio C, Frontali M, Nuovo S, Siotto M, Salomone G, Altavilla R, di Biase L, Scrascia F, Squitti R, Vernieri F.
    Parkinsonism Relat Disord; 2015 Jun 15; 21(6):658-60. PubMed ID: 25864092
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation.
    Suzuki Y, Yoshida K, Aburakawa Y, Kuroda K, Kimura T, Terada T, Kono S, Miyajima H, Yahara O.
    Intern Med; 2013 Jun 15; 52(13):1527-30. PubMed ID: 23812204
    [Abstract] [Full Text] [Related]

  • 16. Ceruloplasmin in neurodegenerative diseases.
    Vassiliev V, Harris ZL, Zatta P.
    Brain Res Brain Res Rev; 2005 Nov 15; 49(3):633-40. PubMed ID: 16269323
    [Abstract] [Full Text] [Related]

  • 17. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Harris ZL, Klomp LW, Gitlin JD.
    Am J Clin Nutr; 1998 May 15; 67(5 Suppl):972S-977S. PubMed ID: 9587138
    [Abstract] [Full Text] [Related]

  • 18. Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia.
    Oide T, Yoshida K, Kaneko K, Ohta M, Arima K.
    Neuropathol Appl Neurobiol; 2006 Apr 15; 32(2):170-6. PubMed ID: 16599945
    [Abstract] [Full Text] [Related]

  • 19. Clinical relevance of heterozygosis for aceruloplasminemia.
    Borges MD, de Albuquerque DM, Lanaro C, Costa FF, Fertrin KY.
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jun 15; 180(4):266-271. PubMed ID: 30901137
    [Abstract] [Full Text] [Related]

  • 20. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    Finkenstedt A, Wolf E, Höfner E, Gasser BI, Bösch S, Bakry R, Creus M, Kremser C, Schocke M, Theurl M, Moser P, Schranz M, Bonn G, Poewe W, Vogel W, Janecke AR, Zoller H.
    J Hepatol; 2010 Dec 15; 53(6):1101-7. PubMed ID: 20801540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.